The Dean’s Advisory Board includes alumni and friends of the College of Pharmacy and Health Sciences at St. John’s who are committed to advancing the College’s and University’s mission and offer individual expertise in relation to the University’s strategic priorities.
Robert Blenderman, P.A., M.B.A. ’01P
Chief Operating Officer
Mr. Blenderman was born and raised in Middle Village, Queens, and attended St. Francis Preparatory School. Given an interest in medicine, he volunteered at NewYork-Presbyterian Queens during his junior and senior years, at which time he was exposed to the Physician Assistant (PA) profession.
This led Mr. Blenderman to St. John’s University, where he enrolled in the Physician Assistant program. He graduated in 2001 and was hired as a trauma surgery critical care PA at St. Vincent’s Catholic Medical Center in addition to being an Adjunct Professor for the PA program at St. John’s.
Mr. Blenderman’s affinity to critical care and the operating room brought him to North Shore University Hospital under the mentorship of Alan Roy Hartman, M.D., where he was hired in the Department of Cardiovascular and Thoracic Surgery. During his 15 years at Northwell Health, he had progressively increasing leadership roles from Chief Critical Care Specialist to Manager of Quality and Education for the Department of Cardiovascular and Thoracic Surgery.
In 2010, Mr. Blenderman obtained his M.B.A. in Quantitative Methodology and Finance from Hofstra University’s Frank G. Zarb School of Business. He was then appointed as the Director of Cardiovascular and Thoracic Surgery at North Shore University Hospital and Long Island Jewish Medical Center, where he oversaw the administrative and clinical operations across both campuses.
As Northwell Health’s footprint grew, the position evolved and Mr. Blenderman became the Corporate Director of Cardiovascular and Thoracic Surgery across Northwell’s eight hospitals, spanning from Staten Island to eastern Long Island, a group that represented the largest volume of cardiac and thoracic surgeons in the Northeast. Mr. Blenderman’s career path came full circle in 2017, when he accepted the position of Chief Operating Officer at NewYork-Presbyterian Queens. In this role, he oversees operations, strategy, emergency management, patient flow, and hospital safety.
Linda M. DaSilva, R.Ph. ‘81GP
Commercial and Market Access Market Development
Ms. DaSilva is currently a sales executive aligned to Deloitte Consulting’s Life Sciences Commercial and Market Access practice based in Parsippany, NJ.
Over the past 10 years, Ms. DaSilva has led business development efforts for top-tier management consulting service organizations. Prior to entering the consulting sector, she spent more than 25 years in the pharmaceutical industry (i.e., generic and ethical pharmaceuticals) in addition to clinical pharmacy practice, providing her clients with a broad perspective of the health-care ecosystem.
As a Life Sciences veteran and licensed pharmacist, Ms. DaSilva has broad experience in health care and life sciences’ commercial launch and market access, marketing, distribution operations, executive governance, and business development. Her success in leading cross-functional teams led to increased responsibility for external partner relationships and operational business performance.
Commercial leadership roles included oversight of trade account managers, customer service, contracting services, US commercial supply chain, service providers and consultants, professional and trade association relationships, and strategic alliances. Executive governance includes corporate planning (i.e., strategic and business planning), as well as Chief of Staff responsibilities to the Chief Executive Officer and Executive Committee.
Business development for life sciences consulting services focused on commercial launch and operations, marketing intelligence, distribution logistics and courier services, and home health-care services. Ms. DaSilva’s business performance and operational success led to increased strategic and executive roles leading cross-functional, executive-sponsored projects related to enterprise process improvements and creation of new organizational capabilities aligned to strategy, resulting in increased revenue and improved profitability. Examples include US commercial distribution operations, enterprise risk management, business continuity planning/information technology disaster recovery, pandemic planning, record retention, mergers and acquisitions due diligence, and asset acquisition integration.
Outside of Deloitte, Ms. DaSilva has served as a volunteer leader with the Healthcare Businesswomen’s Association (HBA) for more than 16 years in multiple global board, local chapter, committee, and advisory roles. Her leadership has been recognized by the HBA through several recognition awards, including HBA Rising Star (2003), Luminary (2014), and President’s Award (2013). She is a frequent speaker and moderator on topics such as gender parity, inclusive leadership, networking, mentorship, and sponsorship.
Ms. DaSilva is a New York State-licensed pharmacist and earned her B.S. degree in Pharmacy from St. John’s University and her M.S. degree in Pharmaceutical Health Care Marketing and Sales Administration from The Arnold & Marie Schwartz College of Pharmacy and Health Sciences.
Michael A. Dorato, Ph.D., DABT, Fellow ATS ’71P, ’73GP, ’76Ph.D.
Senior Vice President, Toxicology and Pharmacology
Dr. Dorato is Senior Vice President of Toxicology and Pharmacology at Inotiv, a BASi company, and site leader of Inotiv Gaithersburg LLC, with overall responsibility for toxicology and pharmacology across Inotiv sites, including strategic and scientific direction of general toxicology (discovery through final registration), vaccine safety, and developmental and reproductive toxicology. He also serves as the Institutional Official, responsible for ensuring compliance with all applicable animal welfare laws, regulations, and policies.
Formerly he was Executive Vice President of Smithers Avanza Toxicology Services, with overall responsibility for the operational, strategic, and scientific direction of general toxicology, pharmacokinetics and toxicokinetic vaccine safety, and business development; Vice President and Chief Security Officer, Global Discovery Services (Covance); and Executive Director, Toxicology, and Greenfield Laboratories Site Head (Eli Lilly and Co.). In these positions he led global organizations in safety and efficacy, lead optimization, investigative and regulatory toxicology, discovery and late phase pathology, animal welfare, molecular and anatomical imaging, in vivo pharmacology (i.e., oncology, neuroscience, cardiovascular and metabolic disease, inflammation, renal, bone, and receptor occupancy), developmental and reproductive toxicology, veterinary medicine, and model development.
Dr. Dorato has been a visiting scholar at St. John’s University’s College of Pharmacy and Health Sciences and is a distinguished alumnus. He has more than 48 years of experience in toxicology (from discovery to final registration), leading drug development decisions in various phases of pharmaceutical research and development; driving organizational growth; implementing change and continuous improvement; developing leaders; moving ideas from concept to practice; building partnerships and alliances; and initiating, leading, and managing contract research organizations/industry relationships.
Dr. Dorato is a graduate of St. John’s University (B.S. in Pharmacy, M.S. in Pharmacology, and Ph.D. in Pharmacology), a diplomat of the American Board of Toxicology, and a Fellow of the Academy of Toxicological Sciences.
Peter J. Micca ’89CBA
Deloitte & Touche LLP
Mr. Micca is a Partner in Deloitte & Touche LLP, with 30 years of experience serving a broad array of clients in all sectors of the health-care, technology, and life sciences industries. He has significant experience with health technology organizations, software as a service organizations, pharmacy benefit management, clinical and diagnostic operations, and emerging growth and private equity financed organizations in life sciences and health technology and services. He has experience applying a deep knowledge of industry sector business issues regarding the emerging trends surrounding consumerism, convergence, cost considerations, emerging regulatory, and compliance issues and consolidation.
Mr. Micca has served as Lead Client Service Partner for prominent domestic and global industry clients, most recently advising Change Healthcare and Oscar Insurance.
He currently is Deloitte’s National Health Tech Marketplace Leader, leading the development of the company’s national industry strategy, including client service, quality, business development, marketing, and eminence surrounding organizations developing the innovative and disruptive technology and services to the health-care and life sciences industry.
Mr. Micca has previously served as Deloitte’s National Audit and Assurance Healthcare Sector Leader and National Assurance and Enterprise Risk Services Industry Leader. He has served and delivered a diverse cross-section of solutions to organizations in the health-care, technology, and life sciences industries, including experience with external audits, assurance and enterprise risk management, corporate governance and compliance, cyber risk, internal control, internal audit, and mergers and acquisitions services. He previously served in Deloitte’s special mergers and acquisitions services group, dedicated to transactions exclusively in the health-care, health technology, and life sciences industries.
Mr. Micca is a speaker and presenter on emerging accounting, financial reporting, and industry issues to external organizations, including HLTH, Med City News, Digital Health Innovation Summit, Rock Health and the Financial Times Health Tech Summit, Financial Executives International, and the JP Morgan Health Conference. He currently serves on the advisory board of the Digital Health Innovation Summit.
He has significant experience working with strategic, operational, and private equity buyers and initial public offerings, SEC accounting and auditing issues, and registration statements and comment letters,
organizational carve-outs and spin-offs, including various portfolio companies of Blackstone, KKR, General Atlantic Partners, TA Associates, and Thomas H. Lee Partners.
Mr. Micca serves on the Board of Advisors of The Peter J. Tobin College of Business at St. John’s University. He is also on the Board of Directors and Chairman of the Audit Committee of Boy Scouts of America.
Representative clients previously served include Aetna, Athena Health, Bristol Myers Squibb, Cardinal Health (including the Catalent Health spin-out), Emdeon, McKesson (including the Change Healthcare spin-out), inVentiv Health Technologies, Medco Health Solutions, Optum, Oscar Health, Quest Diagnostics, United Health Group (including its health technology operations), WebMD, as well as various emerging growth companies in the health-care and technology sectors.
Frank Odeh ’93P
Mr. Odeh owns Virginia-based Prosperity Pharmacy. He graduated with a B.S. degree in Pharmacy from St. John’s University in 1993. Following graduation from, Mr. Odeh worked for more than eight years for a retail chain pharmacy. His career in specialty pharmacy started in Washington D.C., where he focused on HIV/AIDs. His wife, Lisa, earned her B.S. in pharmacy from Duquesne University in Pittsburgh. Like her husband, Ms. Odeh spent several years working for a retail chain pharmacy and later started working at a specialty pharmacy in Virginia.
In 2003, the Odehs opened Prosperity Pharmacy in Fairfax, Virginia, with one additional employee. In 2005, they opened Prosperity Outpatient Pharmacy in Inova Fairfax Hospital, serving newly discharged hospital patients and hospital employees. By 2007, their specialty services had expanded to the point that they decided to open Prosperity Specialty Pharmacy to allow for growth and better patient care.
In 2009, they opened Prosperity Pharmacy Manassas, which, in addition to being a community pharmacy, also served as their durable medical equipment center. At that time, their companies expanded to include more than 50 employees, including pharmacists, pharmacy technicians, a fertility nurse specialist, sales representatives, a billing department, and a human resource officer. Today, the Odehs continue to own and operate four specialty pharmacies in Virginia.
Roger Paganelli ’87P
President and Supervising Pharmacist
Mt. Carmel Pharmacy
Mr. Paganelli is President and Supervising Pharmacist at Mt. Carmel Pharmacy. His family has been in the pharmacy business since 1923, when his grandfather opened his first pharmacy in the Bronx. Mt. Carmel Pharmacy was founded in 1964 by Mr. Paganelli’s father, Roger Sr.
Roger Jr. and his brothers grew up working in the store and learning the business, which they purchased from Roger Sr. in 1992. Since then, Mt. Carmel Pharmacy and the Paganelli family have been recognized by the Arthur Avenue Merchants Association as Merchants of the Year, and The City of New York honored them with a City Council Citation as well as the Mayor’s Office Citation for Community Service.
Mr. Paganelli has also been a spokesperson for FixRx, a statewide advocacy group comprised of 3,000 pharmacists, many of whom are independent pharmacy owners. He has been featured in a number of published articles focused on the increasing challenges faced by independent pharmacies and the role of pharmacy benefit managers in drug pricing and reimbursement rates.
Mr. Paganelli and his brothers are active members of the Pharmacists Society of the State of New York, Inc., New York City Pharmaceutical Society, and the Italian-American Pharmacists Society. They are also very active in their community, providing free services as well as free delivery to homebound customers; meals to homeless, elderly, and sick populations; and holiday gifts and food for children via their local church. Mr. Paganelli and his wife, Joanne, earned their B.S. degrees in Pharmacy from St. John’s University in 1987. They have five children.
Colonel John Spain RET, Pharm.D. ’88P
Senior Director, National Payer Account Medical Lead
Dr. Spain currently serves as a Senior Director, National Payer Account Medical Lead, supporting the US Department of Defense and US Department of Veterans Affairs for Pfizer Inc. He previously served as an Army Pharmacy Officer in a variety of assignments within the United States, Korea, Germany, Saudi Arabia, and Iraq, prior to retiring after 34 years of service. Dr. Spain’s last three positions while on active duty included Pharmacy Director, Walter Reed Army Medical Center; Deputy Commander for Clinical Support, Walter Reed National Military Medical Center; and Army Pharmacy Consultant and Program Manager for the Army Surgeon General.
Dr. Spain and his wife, Monica, have three children Sean (24), Owen (21), and Clare (19). He is active in the American Legion, Knights of Columbus, and Appalachia Service Project. Dr. Spain enjoys reading history books and backpacking in his free time.
Dr. Spain earned a B.S. degree in Pharmacy from St. John’s in 1988. He also earned an M.A. in Public Administration from Bowie State University in 1997 and a Pharm.D. from Rutgers University in 1999.